UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Teclistamab Demonstrates Clinical Activity in Real-World Patients Ineligible for the Pivotal Majestec-1 Trial

Blood, 2023-11, Vol.142 (Supplement 1), p.4741-4741

2023

Volltextzugriff (PDF)

Evaluation of the Functional Landscape of Systemic Immunity in Classical Hodgkin Using a Novel Single Cell Platform (Isolight)

Blood, 2019-11, Vol.134 (Supplement_1), p.3980-3980

2019

Volltextzugriff (PDF)

Final Results of a CTEP Sponsored Phase I Study of Alistertib in Combination with Bortezomib and Rituximab in Relapsed and Refractory Mantle Cell and Low Grade Non-Hodgkin Lymphoma

Blood, 2018-11, Vol.132 (Supplement 1), p.4166-4166

2018

Volltextzugriff (PDF)

Midostaurin in Combination with Idarubicin and Cytarabine (3+7) Induction for FLT3 Positive AML - Very High Complete Response Rates and Transition to Allogeneic Transplantation

Blood, 2018-11, Vol.132 (Supplement 1), p.5216-5216

2018

Volltextzugriff (PDF)

Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma

Blood advances, 2021-03, Vol.5 (5), p.1194-1198

2021

Volltextzugriff (PDF)

Hodgkin Lymphoma Patients Demonstrate Evidence of Systemic Perturbation of the Monocyte-Dendritic Cell Axis

Blood, 2016-12, Vol.128 (22), p.2949-2949

2016

Volltextzugriff (PDF)

Abstract 4895: Hodgkin lymphoma patients demonstrate evidence of chronic activation/exhaustion in circulating T cell subsets

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4895-4895

2016

Volltextzugriff (PDF)

Abstract 4895: Hodgkin lymphoma patients demonstrate evidence of chronic activationexhaustion in circulating T cell subsets

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4895-4895

2016

Volltextzugriff (PDF)

Circulating Memory T Cells Isolated from Hodgkin Lymphoma Patients Display Evidence of Exhaustion and Chronic Activation

Blood, 2014-12, Vol.124 (21), p.4400-4400

2014

Volltextzugriff (PDF)

The appearance of epidural extranodal marginal zone lymphoma (MALToma) on F-18 FDG PET/CT and post hoc PET/MRI fusion

Clinical nuclear medicine, 2011-04, Vol.36 (4), p.303-304

2011

Volltextzugriff (PDF)

Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria

British journal of haematology, 2008-07, Vol.142 (2), p.263-272

2008

Volltextzugriff (PDF)

Capecitabine induced cutaneous hyperpigmentation: report of a case

Journal of drugs in dermatology, 2002-09, Vol.1 (2), p.202

2002

Volltextzugriff (PDF)

Effect of the Terminal Complement Inhibitor Eculizumab on Patient Reported Outcomes in Paroxysmal Nocturnal Hemoglobinuria (PNH): Phase III Triumph Study Results

Blood, 2006-11, Vol.108 (11), p.3770-3770

2006

Volltextzugriff (PDF)

Identification of oligoclonal CD4 T cells in diffuse large B cell lymphomas

Clinical immunology (Orlando, Fla.), 2003-06, Vol.107 (3), p.160-169

2003

Volltextzugriff (PDF)

Rapid, nonradioactive screening for activating ras oncogene mutations using PCR-primer introduced restriction analysis (PCR-PIRA)

Genome research, 1991, Vol.1 (2), p.146-148

1991

Volltextzugriff (PDF)

N‐ras oncongene activation in a patient with γ heavy chain disease

American journal of hematology, 1992-12, Vol.41 (4), p.302-303

1992

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Zeitschrift / Serie

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Teclistamab Demonstrates Clinical Activity in Real-World Patients Ineligible for the Pivotal Majestec-1 Trial

Evaluation of the Functional Landscape of Systemic Immunity in Classical Hodgkin Using a Novel Single Cell Platform (Isolight)

Final Results of a CTEP Sponsored Phase I Study of Alistertib in Combination with Bortezomib and Rituximab in Relapsed and Refractory Mantle Cell and Low Grade Non-Hodgkin Lymphoma

Midostaurin in Combination with Idarubicin and Cytarabine (3+7) Induction for FLT3 Positive AML - Very High Complete Response Rates and Transition to Allogeneic Transplantation

Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma

Hodgkin Lymphoma Patients Demonstrate Evidence of Systemic Perturbation of the Monocyte-Dendritic Cell Axis

Abstract 4895: Hodgkin lymphoma patients demonstrate evidence of chronic activation/exhaustion in circulating T cell subsets

Abstract 4895: Hodgkin lymphoma patients demonstrate evidence of chronic activationexhaustion in circulating T cell subsets

Circulating Memory T Cells Isolated from Hodgkin Lymphoma Patients Display Evidence of Exhaustion and Chronic Activation

The appearance of epidural extranodal marginal zone lymphoma (MALToma) on F-18 FDG PET/CT and post hoc PET/MRI fusion

Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria

Capecitabine induced cutaneous hyperpigmentation: report of a case

Effect of the Terminal Complement Inhibitor Eculizumab on Patient Reported Outcomes in Paroxysmal Nocturnal Hemoglobinuria (PNH): Phase III Triumph Study Results

Identification of oligoclonal CD4 T cells in diffuse large B cell lymphomas

Rapid, nonradioactive screening for activating ras oncogene mutations using PCR-primer introduced restriction analysis (PCR-PIRA)

N‐ras oncongene activation in a patient with γ heavy chain disease

Suchergebnisse filtern